메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

ASEAN Foundation introduced CALM MRI: Children and the No Longer Scary Machine

SINGAPORE, Feb. 27, 2026 -- The ASEAN Foundation organized the regional programme "CALM MRI – Fear to Confidence: Learning through Play with LEGO MRI Kits Programme", implemented across Indonesia and Singapore. The initiative serves as a platform to present the programme's outcomes, which aim to help children better understand Magnetic Resonance Imaging (MRI) procedures through a play-based learning approach. Designed to reduce anxiety and build familiarity, CALM MRI introduces children to the MRI process using specially designed LEGO® MRI kits. By transforming a
- 김갑성 기자
- 2026-02-27 12:39
Basecare Medical (HK.2170) Receives NMPA Approval for Core Product Geri Medium, Unlocking New Opportunities in Assisted Reproduction

SUZHOU, China, Feb. 27, 2026 -- Basecare Medical (02170.HK) has recently encountered a key catalyst——its Gems one-step embryo culture medium has officially obtained the China Class III Medical Device Registration Certificate (National Medical Products Administration Registration No. 20253180071). This represents a core signal of the company's strategic transformation implementation and accelerated domestic substitution layout, and is expected to become an important driver for its valuation repair, warranting close attention. From a market logic perspective, the approval of this product
- 김갑성 기자
- 2026-02-27 10:49
Cynosure Lutronic bolsters its strength in APAC -- The world's fastest-growing medical aesthetics device region, with dual regulatory approvals for the Clarity II™ in China and Japan, February 2026

SINGAPORE, Feb. 27, 2026 -- Cynosure Lutronic, a global leader in energy-based medical aesthetic devices, announced today that Clarity II, its dual-wavelength long-pulse laser platform, has received regulatory approval in China and Japan. This marks a significant expansion of the company's clinically approved laser portfolio across two of Asia's most highly regulated aesthetic markets. "The approval enables the introduction of a single, integrated dual wavelength laser platform designed to support multiple treatment indications and diverse patient profiles and is
- 김갑성 기자
- 2026-02-27 10:33
Checkered Flag Getaways: Agoda Reveals Top Formula 1 Host Destinations Among South Korean Travelers

- Shanghai, Barcelona, and Suzuka lead the list of most popular Formula 1 host destinations SEOUL, South Korea, Feb. 27, 2026 -- The global popularity of Formula 1 (F1) continues to rise, with strong momentum among South Korean fans. Interest increased further following the release of "F1: The Movie" last year, which featured appearances by current F1 drivers including Lewis Hamilton, Max Verstappen, and Lando Norris, introducing the excitement of the sport to a broader audience. With the 2026 FIA Formula One World Championship approaching, digital travel platform Ago
- 황정호 기자
- 2026-02-27 10:05
아고다, 대한민국 여행객 인기 F1 개최지 공개

- 상하이•바르셀로나•스즈카 2026년 상반기 F1 개최 도시 중 대한민국 여행객 선호 여행지 상위 3위권 올라 서울, 대한민국, 2026년 2월 27일 -- 모터스포츠 포뮬러 원(Formula 1, 이하 F1)의 인기가 전 세계적으로 확산되는 가운데, 대한민국에서도 관련 팬층이 점차 확대되고 있다. 특히 지난해 루이스 해밀턴, 막스 베르스타펜, 랜도 노리스 등 현역 F1 드라이버들이 출연한 영화 F1: 더 무비(F1: The Movie)가 흥행에 성공하며 해당 스포츠에 대한 인지도와 관심이 한층 높아졌다. 이 같은 흐름 속에서 디지털 여행 플랫폼 아고다는 2026년 F1 월드 챔피언십을 앞두고, 올해 상반기 개최지 가운데 대한민국 여행객들이 가장 선호한 여행지 순위를 발표했다. 아고다가 분석한 대한민국 여행객 숙박 검색 데이터에 따르면, 중국 상하이가 가장 높은 관심을 받은 F1 개최지로 나타났다. 이어 스페인 바르셀로나, 일본 스즈카, 호주 멜버른, 캐나다 몬트리올, 모나코, 미국 마이애미, 사우디아라비아 제다, 바레인 사키르 순으로 상위 9위를 기록했다. 이는 대한민국 여행객들 사이 아시아를 비롯해
- 황정호 기자
- 2026-02-27 10:05
QCY Announces Upcoming Launch of Track S10: Unleash Your Full Potential

DONGGUAN, China, Feb. 27, 2026 -- QCY, a leader in high-performance wearables, is taking athletes' fitness to the next level with the QCY Track, the ultimate sports smartwatch built for precision, power, and endurance. Packed with cutting-edge features, this game-changing device is designed to keep athletes at the top of their game, whether they are training, competing, or pushing their limits. Precision Performance Tracking for Superior Results Equipped with a 1.43-inch HD AMOLED display, an ultra-high 466 × 466 resolution, and 1000-nit peak brightness, th
- 황정호 기자
- 2026-02-27 10:00
U.S. Investing Champion J Law Expands to Singapore After Record Two-Year Run

SINGAPORE, Feb. 27, 2026 -- Law Wai-Sum, a Hong Kong trader known as J Law, is expanding his investment education business, JLawStock, to Singapore after posting a record 1,499% cumulative return over two years in the top division of the United States Investing Championship. The move marks the first phase of Law's broader international expansion, with Singapore serving as the base to engage retail investors seeking more systematic and professional approaches to trading. A Historic Achievement in a Four-Decade Competition Founded in 1983 by Norman Zada, then a visi
- 황정호 기자
- 2026-02-27 09:30
Fosun International Receives "Certificate of Excellence in Environmental, Social and Governance Reporting" from Hong Kong Management Association

HONG KONG, Feb. 27, 2026 -- On 23 February 2026, The Hong Kong Management Association (HKMA) held the 2025 HKMA Best Annual Reports Awards presentation ceremony in Hong Kong. Fosun International received the "Certificate of Excellence in Environmental, Social and Governance Reporting", underscoring the company's outstanding performance in ESG strategy, environmental protection, social responsibility, corporate governance and information disclosure, and its continued recognition by industry authorities. Since its inception in 1973, the HKMA Best Annual Reports Awards has becom
- 황정호 기자
- 2026-02-27 09:00
Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics

[ 메디채널 김갑성 기자 ] TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data demonstrates its accuracy in detecting rare genetic diseases 40% increase in output to 35 billion reads, up to Q70 quality scores, improved turnaround time, and staggered starts are among the updates to be rolled out on all NovaSeq X systems, advancing precision medicine and delivering compounded value for NovaSeq X customers At AGBT, researchers reveal new findings from studies leveraging Illumina's multiomics solutions SAN DIEGO, Feb. 27, 2026 -
- 김갑성 기자
- 2026-02-27 08:00
ImmVira's Oncolytic Product MVR-T3011 Expanded to BCG-Naïve Bladder Cancer Patients for the First Time with Clinical Data Presented at the 2026 ASCO GU Conference

SUZHOU, China, Feb. 27, 2026 -- Intravesical BCG is the standard of care (SOC) for BCG-naïve high-risk non-muscle-invasive bladder cancer (NMIBC) patients. However, the scarcity of BCG products has become a global phenomenon, and coupled with the side effects of BCG therapy itself, means that a substantial number of patients cannot access effective BCG treatment. Therefore, it is essential to seek better alternative therapies to BCG in order to meet clinical needs. Based on this, ImmVira Group is further expanding the clinical trial of its core oncolytic virus product, MVR-T3011—
- 김갑성 기자
- 2026-02-27 08:00

이전

1 2 3 4 5 6 7 8 9 10

많이 본 기사

최근기사

2026-03-02_MON

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 03월 02일 18시 40분